Aspergillus PCR Early Detection in High Risk Oncohematological Patients
NCT01742026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225
Last updated 2022-03-31
Summary
ADVANCE THERAPY ASPERGILLOSIS INVASIVE BY PCR DETECTION
Conditions
Interventions
- PROCEDURE
-
Aspergillus PCR technique
Aspergillus DNA PCR technique
- PROCEDURE
-
Aspergillus AGA technique
Aspergillus AGA technique
Sponsors & Collaborators
-
Grupo Espanol de trasplantes hematopoyeticos y terapia celular
lead OTHER
Principal Investigators
-
Lourdes Vazquez, MD · University of Salamanca
-
Isabel Ruiz, Md · Hospital Vall d´Hebron
-
Rocio Parody, MD · Hospital Virgen del Rocio
-
Javier Lopez, MD · Hospital Ramon y Cajal
-
Montserrat Rovira, MD · Hospital Clinic of Barcelona
-
Montserrat Batlle, MD · Germans Trias i Pujol Hospital
-
Carlos Vallejo, MD · Hospital Central de Asturias
-
Rosario Varela, MD · Hospital de A Coruña
-
Inmaculada Heras, MD · Hospital Morales Meseguer
-
Joaquin Diaz, MD · Hospital Clinico San Carlos
-
Carlos Solano, MD · Hospital Clinico de Valencia
-
Maria Teresa Olave, MD · Hospital Lozano Blesa
-
David Gallardo, MD · H. Josep Trueta
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-02-28
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Identification of a MOLecuLar Signature in Locally Advanced Cervical Cancer Patients
NCT06016868 ·Status: UNKNOWN
-
Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT00001823 ·Status: RECRUITING
-
Novel Biomarkers for Invasive Aspergillosis
NCT03004092 ·Status: TERMINATED ·Phase: NA
-
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
NCT00899990 ·Status: COMPLETED
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
NCT04213326 ·Status: COMPLETED
-
Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma
NCT00339898 ·Status: COMPLETED
-
Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer
NCT00876408 ·Status: COMPLETED
-
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
NCT03617939 ·Status: RECRUITING
-
Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC
NCT02143492 ·Status: COMPLETED
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma
NCT05100368 ·Status: COMPLETED
-
Prospective Tissue Collection Research Protocol
NCT03517917 ·Status: COMPLETED
-
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
NCT00897767 ·Status: COMPLETED
-
UWCCC Molecular Tumor Board Registry
NCT03023202 ·Status: RECRUITING
-
PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy
NCT00530283 ·Status: COMPLETED
-
Micro Assays for HemATology Malignancies Antibody Treatment
NCT07018310 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Molecular Markers in Cancers and Precancers (MOCA)
NCT05257707 ·Status: WITHDRAWN ·Phase: NA
-
S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
NCT00919425 ·Status: COMPLETED
-
Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
NCT06905262 ·Status: RECRUITING
-
Urine Methylation Markers in UTUC
NCT06805630 ·Status: RECRUITING ·Phase: NA
-
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
NCT04300257 ·Status: RECRUITING
-
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
NCT03265496 ·Status: TERMINATED ·Phase: NA
-
The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma
NCT05344027 ·Status: COMPLETED
-
Biomarker Identification for Bladder Cancer Patients
NCT02053662 ·Status: TERMINATED